Page last updated: 2024-08-24

temoporfin and Minimal Disease, Residual

temoporfin has been researched along with Minimal Disease, Residual in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dhamiyati, W; Fles, R; Hariwiyanto, B; Haryana, SM; Herdini, C; Indrasari, SR; Karakullukcu, B; Romdhoni, AC; Stoker, SD; Tan, IB; Widayati, K; Wildeman, MA1
De Boer, JP; Karakullukcu, B; Tan, B; Van Veen, R; Wegman, J1
Hariwiyanto, B; Herdini, C; Indrasari, SR; Karakullukcu, MB; Tan, IB; Timmermans, AJ; Wildeman, MA1

Trials

1 trial(s) available for temoporfin and Minimal Disease, Residual

ArticleYear
Photodynamic therapy as salvage therapy for patients with nasopharyngeal carcinoma experiencing local failures following definitive radiotherapy.
    Photodiagnosis and photodynamic therapy, 2015, Volume: 12, Issue:3

    Topics: Adult; Carcinoma; Chemotherapy, Adjuvant; Female; Humans; Kaplan-Meier Estimate; Male; Mesoporphyrins; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Photochemotherapy; Photosensitizing Agents; Salvage Therapy

2015

Other Studies

2 other study(ies) available for temoporfin and Minimal Disease, Residual

ArticleYear
Surgical debulking combined with photodynamic therapy to manage residual extramedullary plasmacytoma of the nasopharynx.
    Photodiagnosis and photodynamic therapy, 2011, Volume: 8, Issue:3

    Topics: Disease-Free Survival; Endoscopy; Follow-Up Studies; Humans; Male; Mesoporphyrins; Middle Aged; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Neoplasm, Residual; Photochemotherapy; Photosensitizing Agents; Plasmacytoma; Radiotherapy Dosage; Remission Induction

2011
Remarkable response to photodynamic therapy in residual T4N0M0 nasopharyngeal carcinoma: a case report.
    Photodiagnosis and photodynamic therapy, 2012, Volume: 9, Issue:4

    Topics: Adult; Carcinoma; Humans; Male; Mesoporphyrins; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Neoplasm, Residual; Photochemotherapy; Photosensitizing Agents

2012